Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118)
11/2009
11/25/2009EP2121583A1 Heteroaryl-substituted serine amides
11/25/2009EP2120963A2 Substituted tetracycline compounds for treatment of inflammatory skin disorders
11/25/2009EP2120911A1 Amide and urea derivatives for the treatment of metabolic diseases
11/25/2009CN101589028A Process for production of phenylalanine derivatives having quinazolinedione skeletons and intermediates for the production
11/25/2009CN101585781A Preparing method of N, N-dimethylbenzamide
11/25/2009CN100562513C Benzamide derivative or salt thereof
11/24/2009CA2421504C 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
11/24/2009CA2418794C Calcium receptor antagonists
11/24/2009CA2385882C Tyrosine derivatives
11/24/2009CA2385859C 2'-substituted 1,1'-biphenyl-2-carboxamides, processes for their preparation, their use as medicament, and pharmaceutical preparations comprising them
11/19/2009WO2009138778A1 Cyclopropyl benzamide derivatives as intermediates for cytokine inhibitors
11/19/2009US20090286990 Process for preparing irbesartan
11/19/2009US20090286841 Certain chemical entities, compositions, and methods
11/19/2009US20090286828 2-amino-1-phenylethylcarboxamide derivatives
11/19/2009US20090285780 Peg linker compounds and biologically active conjugates thereof
11/18/2009CN101583593A Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof
11/18/2009CN101580480A Method for preparing substance-glutamine for increasing immunoregulation of grice
11/17/2009US7619097 N-(trans-2,3-di-n-amyl-2-butenoic acid amide)-L-phenylglycinamide;treating hypertension, deficiency of magnesium ion bound to the plasma membranes of their somatic cells; sodium-sensitive essential hypertension and Type 2 insulin-resistant diabetes mellitus
11/17/2009US7619006 Conjugates with organic acids; uses thereof in the treatment of psychotic and/or proliferative disorders and diseases and as chemosensitizing agents; the organic acids are selected to reduce side effects induced by the psychotropic drugs and/or to exert an anti-proliferative activity
11/17/2009US7618996 Diaryl ether derivatives and uses thereof
11/17/2009US7618981 Imidazopyridinyl-benzamide anti-cancer agents
11/17/2009CA2383364C Methods of preparing substituted tetracyclines with transition metal-based chemistries
11/12/2009WO2009106551A3 Contrast agents
11/12/2009WO2009092680A3 Antibiotic compounds
11/12/2009US20090281103 Renin Inhibitors
11/12/2009US20090281085 3-(4-fluorophenyl)-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic activity
11/12/2009US20090278087 Oxygen Scavenging Compositions and Packaging Comprising Said Compositions
11/11/2009EP2116599A1 Reagent for introduction of protein or gene
11/11/2009EP2116525A1 Process for the preparation of tigecycline in the amorphous form
11/11/2009EP2114868A2 Novel polymorphic forms of milnacipran hydrochloride
11/11/2009EP2114867A1 Aminoamides as orexin antagonists
11/11/2009EP2114865A1 Processes for purification of tigecycline
11/11/2009EP2114415A1 Methods and compounds for the targeted delivery of agents to bone for interaction therewith
11/11/2009EP1713823B1 Hcv ns-3 serine protease inhibitors
11/11/2009EP1255726B1 (r)-2-aryl-propionamides, useful in the inhibition of il-8 induced chemiotaxis of neutrophils
11/11/2009CN101578261A Heteroaryl-substituted serine amides
11/11/2009CN101578091A Composition for external application to skin
11/11/2009CN101575301A Preparation method of 2-amino-5-chlorobenzamide
11/11/2009CN101575300A Production method of S-2-aminobutanamide
11/05/2009WO2009132979A1 4-trimethylammonio-butyrates as cpt2 inhibitors
11/05/2009WO2009132978A1 4-dimethylaminobutyric acid derivatives
11/05/2009WO2009113828A9 Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid
11/05/2009WO2009100996A3 Process for preparing pyrazole functionalized benzodiazepinones
11/05/2009WO2009080203A3 Aminobenzamide derivatives as useful agents for controlling animal parasites
11/05/2009US20090275766 Process for the preparation of tigecycline in the amorphous form
11/05/2009CA2722114A1 4-trimethylammonio-butyrates as cpt2 inhibitors
11/05/2009CA2722087A1 4-dimethylaminobutyric acid derivatives
11/03/2009US7612215 No racemization during cyclization, decarbalkoxylation, decarboxylation of intermediate; separation of diastereoisomers by recrystallization; no use of toxic, expensive catalysts; Levetiracetam; treatment, prevention of hypoxic, ischemia of central nervous system
11/03/2009US7612214 Organic amine salts of glutamic acid derivatives and their application
11/03/2009US7612053 7-Substituted fused ring tetracycline compounds
11/03/2009US7612036 Such as methyl (2S,5S,8R/S)-8-acetamido-2-allyl-9-[6-allyl-9-tert-butoxycarbonyl-9H-carbazol-3-yl]-3,6-diaza-5-{3-[(2,2,5,7,8-pentamethylchroman-6-sulfonyl)-guanidino]propyl}-4,7-dioxononanoate; for treatment of bacterial infections, such as those caused by vancomycin resistant microorganisms
10/2009
10/29/2009US20090270365 such as N-(2,4-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-2-(piperidin-1-ylmethyl)biphenyl-4-carboxamide, having vanilloid receptor 1 antagonistic activity, used as analgesics
10/29/2009CA2720818A1 Substituted phenoxybenzamides
10/28/2009EP2111399A2 Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
10/28/2009EP2111391A1 New unsaturated fatty amino-acid derivatives and use thereof in dermal cosmetology
10/28/2009EP2111223A1 Amine derivative compounds for treating ophthalmic diseases and disorders
10/28/2009CN101565385A Pigling intestinal tract nutrition regulation and control substance N-carbamoylglutamine and preparation method
10/28/2009CN101565384A Cyclodextrin modified monolayer graphite, supramolecular complex thereof, preparation method and application
10/27/2009US7608739 2,3-Dihydrooxadiazoles such as 3-acetyl-5-(2,5-difluorophenyl)-2-phenyl-2,3-dihydro-1,3,4-oxadiazole and 3-[3-acetyl-5-(2,5-difluorophenyl)-2-phenyl-2,3-dihydro-1,3,4-oxadiazol-2-yl]-N,N-dimethylpropan-1-amine that are useful for treating cancer
10/27/2009US7608590 19-(7-Methoxy-2-phenyl-quinolin-4-yloxy)-2, 16-dioxo-3,15,17-triaza-tricyclo[15.3.0.0*4,6*]icos-7-ene-4,14-dicarboxylic acid 4-ethyl ester 14-methyl ester, for example; inhibits the NS3 protease of flavivirus such as hepatitis C virus (HCV)
10/22/2009WO2009129387A2 Cationic lipids and uses thereof
10/22/2009WO2009128521A1 Cysteine protease inhibitor
10/22/2009US20090264534 Selective androgen receptor modulators
10/22/2009US20090264533 Methods and Compositions for Modulating RHO-Mediated Gene Transcription
10/21/2009EP2109602A2 Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
10/21/2009EP1383778B1 Agonists and antagonists of sphingosine-1-phosphate receptors
10/21/2009CN101560171A Method for preparing 5-(N,N-dibenzylglycyl) salicylamide
10/21/2009CN100551910C Styryl compound modified by azo-containing heterocyclic and use thereof
10/20/2009CA2585898C Use of (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4-thaizolyl)methyl)amino)-carbonyl)valinyl)amino)-2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane in combination with another protease inhibitor for treating hiv infection
10/15/2009WO2009125861A1 Cysteine protease inhibitor
10/15/2009WO2009125853A1 Homocysteine synthase inhibitor
10/15/2009WO2009124458A1 Phenylcyclobutylamide derivatives and their stereoisomers, the preparing processes and the uses thereof
10/15/2009WO2009066072A3 Inhibitors of 17beta-hydroxysteroid dehydrogenase
10/15/2009US20090258900 Amide derivative
10/15/2009US20090258884 Substituted amides
10/15/2009US20090258842 such as 7-(2,4-difluorophenyl)sancycline, used for the treatment of bacterial infections in mammals
10/15/2009CA2725425A1 Homocysteine synthase inhibitor
10/14/2009CN101558056A Process for production of anthranilamide compound
10/14/2009CN101555215A Preparation technology of doxycycline hydrochloride for injection
10/14/2009CN101555214A Phenylcyclobutylacylamide derivative as well as optical isomer, preparation method and application thereof
10/13/2009US7601872 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell
10/13/2009US7601708 Providing sustained systemic concentrations of therapeutic or prophylactic agents such as gamma-aminobutyric acid derivatives following oral adiminstration to animals
10/13/2009US7601706 Bile-acid conjugates providing for sustained systemic concentration of drugs
10/13/2009US7601674 α-oxygenated or α-thiolated carboxylic acid phenethylamide derivatives
10/13/2009CA2370830C Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors
10/08/2009WO2009124022A1 2 -aminotetralin derivatives as mu opioid receptor antagonists
10/08/2009US20090253935 Preparation of iodixanol
10/08/2009US20090253703 Organic compounds
10/08/2009US20090253701 such as (2S,4S,5S,7S)-5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxy-propoxy)-benzyl]-8-methyl-nonanoic acid (2-phenoxy-ethyl)-amide, having renin-inhibiting properties, used for the treatment of hypertension, cardiovascular, vision, neurodegenerative, kidney and liver disorders
10/08/2009US20090253672 Cathepsin Cysteine Protease Inhibitors
10/08/2009US20090253166 Conjugation of Peptides
10/07/2009CN100546976C Nitroaniline-based alkylating agents and their use as prodrugs
10/06/2009US7598235 Gonane ring substituted with hydroxy group and alkylamide derivatives used for achieving sustained systemic concentrations of therapeutic or prophylactic GABA(gamma-aminobutyric acid)analogs following administration to animals
10/06/2009CA2301377C N-aroylphenylalanine derivatives
10/01/2009WO2009118474A1 Method for preparing combretastatin
10/01/2009US20090247627 Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
10/01/2009US20090247506 Antibacterial agents
10/01/2009US20090247472 Type 1, 4-naphtoquinone compounds, compositions comprising them and use of these compounds as anti-cancer agents
10/01/2009CA2716541A1 Method for preparing combretastatin
09/2009
09/30/2009EP2105433A1 Modular scaffold for the design of specific molecules for the use as peptidomimetics and inhibitors of protein interaction
1 ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ... 162